| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |